Jubiliant Life gets ANDA approval for its hypertension drug
Jubiliant Life Sciences Ltd has received the final Abbreviated New Drug Application (ANDA) approval for its drug Olmesartan Medoxomil, the […]
Say something
Wednesday
May
Upcoming Event
Jubiliant Life Sciences Ltd has received the final Abbreviated New Drug Application (ANDA) approval for its drug Olmesartan Medoxomil, the […]
Enter your email to receive a weekly round-up of our best posts.